University of Chicago Visiting Professor Series: Immunotherapy
This activity is part of a continuing series sponsored by the University of Chicago designed to improve physicians' clinical practice. This session is meant to provide physicians with current information on immunotherapy strategies and its use in hematologic malignancies.
This activity has been designed to meet the educational needs of hematologist-oncologists and any other healthcare professionals that manage patients with hematologic malignancies.
At the conclusion of this activity, participants will be able to:
- Summarize the data supporting the use of immunotherapy in hematologic malignancies;
- Describe forms of immune therapy for hematologic malignancies;
- Describe the elements of an effective anti-tumor immune response;
- Outline current immunotherapy strategies;
- Recite data from completed immunotherapy combinations and describe future clinical trials.
Michael R. Bishop, MD
Professor of Medicine
Director, Hematopoietic Stem Cell Transplantation Program
Jason J. Luke, MD, FACP
Assistant Professor of Medicine
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.